Compare Oracle Corporation (ORCL) vs Twist Bioscience Corp (TWST) Price & Performance

Oracle CorporationTrade

Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Oracle Corporation vs Twist Bioscience Corp — how do they compare? Oracle Corporation trades at $127.14 (market cap $365.96B), while Twist Bioscience Corp trades at $93.82 (market cap $5.97B). The key difference: Oracle Corporation is far larger — about 61.3× Twist Bioscience Corp's market cap, and Oracle Corporation pays a 1.57% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

	ORCL	TWST
Market Cap	$365.96B	$5.97B
Sector	Technology	Health
52-Week High	$328.33	$102.88
52-Week Low	$121.37	$24.16
Enterprise Value	$495.21B	$5.89B
Dividend Yield	1.57%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oracle Corporation

Oracle Corporation (ORCL) trades at $125.86, up 3.7% with strong recent earnings beats. The stock shows bearish technical signals but maintains robust fundamentals with 21.67% net margins and consistent revenue growth. Recent AI partnerships and infrastructure investments position Oracle as a key player in the enterprise cloud and AI markets, though high valuation multiples and significant debt levels warrant caution.

Oracle presents a compelling growth story driven by AI infrastructure demand, with analyst consensus strongly bullish (65% buy ratings) and a $253.30 price target representing significant upside. Key risks include high leverage, competitive pressures, and execution challenges in capital-intensive AI expansion. The upcoming Q2 2026 earnings report on June 10 will be critical for validating the AI growth narrative.

Twist Bioscience Corp

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ORCL

Credit markets warn of rising risks as defaults climb and real estate delinquencies hit crisis levels.Seeking Alpha · 12 hours agoBearish Oracle shares hit key support and show oversold signs, hinting at a possible rebound soon.FXEmpire · 1 day agoBullish Big tech's hidden debt hits $1.65T, raising investor risk amid AI investment surge.Finbold · 1 day agoBearish View details →

TWST

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 1 day agoNeutral View details →

About Oracle Corporation

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.